Research: quality of life and the risk of progression

#MSBlog : Poor health-related quality of life predicts a poorer prognosis in MS. Let's change this! Tepavcevic et al. Predictive value o...

Research: predicting response to 1st-line DMTs

#MSBlog : Are you being treated-2-target? If no ask your neurologist why not! Epub : Romeo et al. Clinical and MRI predictors of response to...

NEDA: defining a cure

#MSBlog : Defining an MS cure. "I have been having several recent discussions with colleagues about whether or not we can cure MS. I th...

Research: natalizumab works within a few months

#MSBlog : Natalizumab starts working within 2-3 months. Therefore any relapse destined to  happen in the first 2-3months will probably occur...

Treat-2-Target: NEDA (no evidence of disease activity)

"I would appreciate your comments on the following beta version of a treatment or monitoring algorithm for relapsing MSers. The idea is...